Cancer Derived Organoids for Drug Discovery in Liver Cancers
Part of the Surgical Grand Rounds Series - Florin M. Selaru, MD identifies the utility and limitations of using patient derived organoids for drug screening in liver cancers.
Director, Meyerhoff Inflammatory Bowel Disease Center
Associate Professor of Medicine
Dr. Selaru is currently an Associate Professor of Medicine and Oncology, Division of Gastroenterology and Hepatology and Sidney Kimmel Cancer Center, Johns Hopkins University. He is also a member of the Institute of Nanobiotechnology at ...